STM Pharma PRO srl Report issue

For profit Phase 2

Organization Overview

First Clinical Trial
2020
NCT04449133
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

STM Pharma PRO srl

Active Ingredients

Drugs in Phase 2 Trials (2)

ad981 (1 trial)

reboxetine (Edronax) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Apnea (Phase 2)

Sleep Apnea, Obstructive (Phase 2)

Sleep Apnea Syndromes (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2